SCHEMBL19862793

SCHEMBL19862793

CC(C)(C)c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc(-c4ccccc4)cc3)c2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.51
KMT2A Q03164 6/20 0.51
KIF11 P52732 2/20 0.49
CYP19A1 P11511 1/20 0.49
TNF P01375 1/20 0.46
NOD1 Q9Y239 1/20 0.46
LMNA P02545 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
ADORA3 P0DMS8 2/20 0.45
ADORA1 P30542 2/20 0.45
ADORA2B P29275 1/20 0.45
MCL1 Q07820 1/20 0.44
RAB9A P51151 2/20 0.43
MAPT P10636 2/20 0.43
TDP1 Q9NUW8 2/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
L3MBTL1 Q9Y468 1/20 0.43
DHODH Q02127 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19735240 1.00 MEN1 (0.51) MEN1KMT2AKIF11CYP19A1TNF
SCHEMBL13203368 0.96 MEN1 (0.49) MEN1KMT2AKIF11CYP19A1TNF
SCHEMBL13203384 0.96 MEN1 (0.47) MEN1KMT2AKIF11CYP19A1TNF
SCHEMBL18326879 0.95 CYP19A1 (0.47) MEN1KMT2AKIF11CYP19A1TNF
SCHEMBL23959669 0.89 MEN1 (0.49) MEN1KMT2AKIF11CYP19A1ADORA3
SCHEMBL28316619 0.89 KDM4E (0.43) MEN1KMT2AKIF11CYP19A1TNF
SCHEMBL19862807 0.89 MEN1 (0.46) MEN1KMT2AKIF11CYP19A1ADORA3
SCHEMBL13203143 0.89 CYP19A1 (0.52) MEN1KMT2AKIF11CYP19A1ADORA3
SCHEMBL19862789 0.88 KIF11 (0.57) MEN1KMT2AKIF11CYP19A1ADORA3
SCHEMBL22058528 0.87 MEN1 (0.58) MEN1KMT2AKIF11LMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same LG CHEM, LTD. (KR) 2019-03-12 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME LG CHEM, LTD. (KR) 2018-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10230056-B2 Heterocyclic compound and organic light emitting element comprising same CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885KIF11 2816/4885
US-20180047914-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT EMITTING ELEMENT COMPRISING SAME CRY1, CRY2, NR2E3 MEN1 798/4885KMT2A 177/4885KIF11 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.